UB Paderborn / Katalog / Suche / in CDI

1 – 22 von 22

Sortiert nach

Metabolic endotoxemia is dictated by the type of lipopolysaccharide

Cell reports (Cambridge), 2021-09, Vol.36 (11), p.109691-109691, Article 109691

2021

Volltextzugriff (PDF)

Muramyl Dipeptide-Based Postbiotics Mitigate Obesity-Induced Insulin Resistance via IRF4

Cell metabolism, 2017-05, Vol.25 (5), p.1063-1074.e3

2017

Volltextzugriff (PDF)

Bacterial peptidoglycan stimulates adipocyte lipolysis via NOD1

PloS one, 2014-05, Vol.9 (5), p.e97675-e97675

2014

Volltextzugriff (PDF)

Statins activate the NLRP3 inflammasome and impair insulin signalling via p38 and mTOR

American journal of physiology: endocrinology and metabolism, 2020-07, Vol.319 (1), p.E110-E116

2020

Volltextzugriff (PDF)

Postbiotics for NOD2 require nonhematopoietic RIPK2 to improve blood glucose and metabolic inflammation in mice

American journal of physiology: endocrinology and metabolism, 2020-04, Vol.318 (4), p.E579-E585

2020

Volltextzugriff (PDF)

Fluvastatin causes NLRP3 inflammasome-mediated adipose insulin resistance

Diabetes (New York, N.Y.), 2014-11, Vol.63 (11), p.3742-3747

2014

Volltextzugriff (PDF)

Tyrosine kinase inhibitors of Ripk2 attenuate bacterial cell wall-mediated lipolysis, inflammation and dysglycemia

Scientific reports, 2017-05, Vol.7 (1), p.1578-13, Article 1578

2017

Volltextzugriff (PDF)

Gut microbiota impairs insulin clearance in obese mice

Molecular metabolism (Germany), 2020-12, Vol.42, p.101067-101067, Article 101067

2020

Volltextzugriff (PDF)

The NLRP3 inflammasome regulates adipose tissue metabolism

Biochemical journal, 2020-03, Vol.477 (6), p.1089-1107

2020

Volltextzugriff (PDF)

Statin Therapy Negatively Impacts Skeletal Muscle Regeneration and Cutaneous Wound Repair in Type 1 Diabetic Mice

Frontiers in physiology, 2017-12, Vol.8, p.1088-1088

2017

Volltextzugriff (PDF)

Inflammation promotes adipocyte lipolysis via IRE1 kinase

The Journal of biological chemistry, 2021-01, Vol.296, p.100440-100440, Article 100440

2021

Volltextzugriff (PDF)

NOD2 in hepatocytes engages a liver-gut axis to protect against steatosis, fibrosis, and gut dysbiosis during fatty liver disease in mice

American journal of physiology: endocrinology and metabolism, 2020-08, Vol.319 (2), p.E305-E314

2020

Volltextzugriff (PDF)

Statins Promote Interleukin-1β-Dependent Adipocyte Insulin Resistance Through Lower Prenylation, Not Cholesterol

Diabetes (New York, N.Y.), 2019-07, Vol.68 (7), p.1441-1448

2019

Volltextzugriff (PDF)

2017-P: Gut Microbes after Bariatric Surgery in Humans Improve Glucose Control in Mice without Fat Loss

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

Is immunity a mechanism contributing to statin-induced diabetes?

Adipocyte, 2015-10, Vol.4 (4), p.232-238

2015

Volltextzugriff (PDF)

2036-P: Gut Microbes Regulate Insulin Clearance in Mice

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

Exploration of BAY 11-7082 as a Potential Antibiotic

ACS infectious diseases, 2022-01, Vol.8 (1), p.170-182

2022

Volltextzugriff (PDF)

22: NOD2 immunity protects against obesity-induced inflammation and insulin resistance

Cytokine (Philadelphia, Pa.), 2014-11, Vol.70 (1), p.33-33

2014

Volltextzugriff (PDF)

22

Cytokine (Philadelphia, Pa.), 2014-11, Vol.70 (1), p.33

2014

Volltextzugriff (PDF)

Bacterial Peptidoglycan Stimulates Adipocyte Lipolysis via NOD1: e97675

PloS one, 2014-05, Vol.9 (5)

2014

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Metabolic endotoxemia is dictated by the type of lipopolysaccharide

Muramyl Dipeptide-Based Postbiotics Mitigate Obesity-Induced Insulin Resistance via IRF4

Bacterial peptidoglycan stimulates adipocyte lipolysis via NOD1

Statins activate the NLRP3 inflammasome and impair insulin signalling via p38 and mTOR

Postbiotics for NOD2 require nonhematopoietic RIPK2 to improve blood glucose and metabolic inflammation in mice

Fluvastatin causes NLRP3 inflammasome-mediated adipose insulin resistance

Defective NOD2 peptidoglycan sensing promotes diet‐induced inflammation, dysbiosis, and insulin resistance

Tyrosine kinase inhibitors of Ripk2 attenuate bacterial cell wall-mediated lipolysis, inflammation and dysglycemia

Gut microbiota impairs insulin clearance in obese mice

The NLRP3 inflammasome regulates adipose tissue metabolism

Statin Therapy Negatively Impacts Skeletal Muscle Regeneration and Cutaneous Wound Repair in Type 1 Diabetic Mice

Inflammation promotes adipocyte lipolysis via IRE1 kinase

NOD2 in hepatocytes engages a liver-gut axis to protect against steatosis, fibrosis, and gut dysbiosis during fatty liver disease in mice

Statins Promote Interleukin-1β-Dependent Adipocyte Insulin Resistance Through Lower Prenylation, Not Cholesterol

2017-P: Gut Microbes after Bariatric Surgery in Humans Improve Glucose Control in Mice without Fat Loss

Is immunity a mechanism contributing to statin-induced diabetes?

2036-P: Gut Microbes Regulate Insulin Clearance in Mice

Exploration of BAY 11-7082 as a Potential Antibiotic

22: NOD2 immunity protects against obesity-induced inflammation and insulin resistance

22

Defective NOD 2 peptidoglycan sensing promotes diet‐induced inflammation, dysbiosis, and insulin resistance

Bacterial Peptidoglycan Stimulates Adipocyte Lipolysis via NOD1: e97675

Suchergebnisse filtern